Samira Sakhia
Tracked across 2 events · 13 articles · First seen Aug 20, 2026 · Last active Sep 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Samira Sakhia, CEO of Knight Therapeutics, announced the launch and highlighted its strategic importance.
Aug 20, 2026 · 6 articles
Regulatory
Impact: Samira Sakhia, as President and CEO of Knight Therapeutics, announced the approval and highlighted its significance for the company's Latin American expansion.
Sep 01, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Samira Sakhia live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard